Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
107 Leser
Artikel bewerten:
(0)

Zimmer Launches PathFinder NXT Minimally Invasive Pedicle Screw System / Intuitive New System Designed to Accommodate Multiple Surgical Approaches and Expedite MIS Spinal Procedures

SAN DIEGO, Feb. 17, 2011 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal care, today announced the launch of the PathFinder NXT(TM) System at the 2011 American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Diego, CA. The PathFinder NXT System builds on the legacy and clinical success of the original PathFinder Minimally Invasive Pedicle Screw System to provide an intuitive and flexible system for a range of minimally invasive (MIS) spinal procedures.

The PathFinder NXT System is an MIS pedicle screw system that facilitates both mini-open and percutaneous approaches. The system enables enhanced reduction, compression, distraction and bone decortications capabilities, and gives surgeons the ability to efficiently complete multi-level constructs.

"The PathFinder NXT System provides unprecedented options for our surgeons and their patients," said Steve Healy, President, Zimmer Spine. "The system's innovative instrumentation and streamlined surgical technique facilitate easier procedures. Early clinical feedback in over 150 cases has been excellent and we expect PathFinder NXT System to become a key component of our portfolio."

MIS approaches are among the fastest growing procedural solutions for patients requiring spinal fusions. Each year, more than 40,000 patients undergo MIS spine surgery. MIS surgery utilizes small incisions, minimizing blood loss and potentially expediting the surgical procedure and rehabilitation. The innovative PathFinder NXT System supports a range of MIS spinal approaches, enabling surgeons the flexibility to treat the unique needs of each patient.

To learn more about the PathFinder NXT System, visit the Zimmer exhibit at the 2011 AAOS annual meeting.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2010 sales were approximately $4.2 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

Zimmer Holdings, Inc.

CONTACT: Media, Garry R. Clark, +1-574-372-4493, garry.clark@zimmer.com,
or Investors, Paul G. Blair, +1-574-371-8042, paul.blair@zimmer.com

Web Site: http://www.zimmer.com/

© 2011 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.